Scilex Holding (SCLXW) Accounts Payables (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Accounts Payables of $101.6 million in Q1 2026, up 17.75% quarter-over-quarter from $86.3 million in Q4 2025, and up 77.41% on a YoY basis from $57.3 million in Q1 2025.

Scilex Holding (SCLXW) Accounts Payables (2021 - 2026) Analysis & Trends

Scilex Holding's Accounts Payables history runs 6 years deep, the most recent figure standing at $101.6 million for Q1 2026.

  • In Q1 2026, Accounts Payables rose 77.41% year-over-year to $101.6 million; the TTM figure through Mar 2026 stood at $101.6 million (up 77.41% YoY), while the FY2025 annual figure was $86.3 million, up 63.94% from the prior year.
  • Accounts Payables was $101.6 million for Q1 2026 at Scilex Holding, up from $86.3 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $101.6 million in Q1 2026 to a low of $41003.0 in Q1 2022.
  • Historically, Accounts Payables has averaged $30.7 million across 5 years, with a median of $9.8 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Accounts Payables plunged 98.16% in 2022, then soared 53473.08% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $79000.0 in 2022, then jumped by 254.43% to $280000.0 in 2023, then surged by 18692.86% to $52.6 million in 2024, then soared by 63.94% to $86.3 million in 2025, then advanced by 17.75% to $101.6 million in 2026.
  • The last three Accounts Payables figures came in at $101.6 million (Q1 2026), $86.3 million (Q4 2025), and $67.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -19.33 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.03 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 10.46 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 33.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 3.86 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 645.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 4.51 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 4.23 Bn
10 Scilex Holding - - 4.15 Mn 101.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 101.58 Mn
Dec 31, 2025 86.27 Mn
Sep 30, 2025 67.36 Mn
Jun 30, 2025 59.16 Mn
Mar 31, 2025 57.26 Mn
Dec 31, 2024 52.62 Mn
Sep 30, 2024 346,000.00
Jun 30, 2024 41.79 Mn
Mar 31, 2024 42.22 Mn
Dec 31, 2023 280,000.00
Sep 30, 2023 2.04 Mn
Jun 30, 2023 78,000.00
Mar 31, 2023 9.82 Mn
Dec 31, 2022 79,000.00
Sep 30, 2022 809,292.00
Jun 30, 2022 598,646.00
Mar 31, 2022 41,003.00
Dec 31, 2021 4.28 Mn
Sep 30, 2021 43,569.00
Jun 30, 2021 20,025.00